Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jamjoom Pharmaceuticals Factory | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 12.35B | 30.1x | 0.93 | SAR 176.40 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.2% Upside | Upgrade to Pro+ | |
Astra Indust | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 12.23B | 21.4x | 0.97 | SAR 152.90 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.3% Upside | Upgrade to Pro+ | |
Saudi chemical | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 6.28B | 22.3x | 1.35 | SAR 7.45 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SPIMACO | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 2.98B | 49.4x | 0.25 | SAR 24.80 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.6% Upside | Upgrade to Pro+ | |
Middle East Pharmaceutical | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 2.39B | 27x | 1.43 | SAR 119.50 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.6% Upside | Upgrade to Pro+ | |
Qomel | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 401.80M | 18.1x | 1.42 | SAR 57.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Almujtama Alraida Medical Co SJSC | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 294.69M | SAR 31.02 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |